Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.275 AUD | +3.77% | -9.84% | +30.95% |
Apr. 24 | Australian Shares Finish Session Flat as Q1 Inflation Eases | MT |
Apr. 24 | St Barbara's Gold Sales Rise 20% in March Quarter; Shares Up 3% | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.18 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Most analysts recommend that the stock should be sold or reduced.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Gold
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+30.95% | 147M | B | ||
+3.24% | 49.27B | A- | ||
+19.45% | 32.63B | B | ||
-2.42% | 29.96B | B+ | ||
+12.88% | 24.43B | B | ||
+10.62% | 11.31B | B | ||
+27.61% | 9.95B | B- | ||
-.--% | 8.61B | - | B- | |
+14.84% | 8.27B | A- | ||
+2.99% | 8.19B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBM Stock
- Ratings St Barbara Limited